Literature DB >> 31787613

Are we ready to use precision medicine in chronic myeloid leukemia practice?

Dennis Dong Hwan Kim1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31787613      PMCID: PMC6959187          DOI: 10.3324/haematol.2019.231753

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Genomic Classification and Prognosis in Acute Myeloid Leukemia.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Hartmut Döhner; Peter J Campbell; Lars Bullinger; Verena I Gaidzik; Peter Paschka; Nicola D Roberts; Nicola E Potter; Michael Heuser; Felicitas Thol; Niccolo Bolli; Gunes Gundem; Peter Van Loo; Inigo Martincorena; Peter Ganly; Laura Mudie; Stuart McLaren; Sarah O'Meara; Keiran Raine; David R Jones; Jon W Teague; Adam P Butler; Mel F Greaves; Arnold Ganser; Konstanze Döhner; Richard F Schlenk
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

Review 2.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

Review 3.  Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia.

Authors:  Susan Branford; Dennis Dong Hwan Kim; Jane F Apperley; Christopher A Eide; Satu Mustjoki; S Tiong Ong; Georgios Nteliopoulos; Thomas Ernst; Charles Chuah; Carlo Gambacorti-Passerini; Michael J Mauro; Brian J Druker; Dong-Wook Kim; Francois-Xavier Mahon; Jorge Cortes; Jerry P Radich; Andreas Hochhaus; Timothy P Hughes
Journal:  Leukemia       Date:  2019-06-17       Impact factor: 11.528

4.  Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.

Authors:  M Schmidt; J Rinke; V Schäfer; S Schnittger; A Kohlmann; E Obstfelder; C Kunert; J Ziermann; N Winkelmann; E Eigendorff; T Haferlach; C Haferlach; A Hochhaus; T Ernst
Journal:  Leukemia       Date:  2014-09-12       Impact factor: 11.528

5.  Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Authors:  Mojca Jongen-Lavrencic; Tim Grob; Diana Hanekamp; François G Kavelaars; Adil Al Hinai; Annelieke Zeilemaker; Claudia A J Erpelinck-Verschueren; Patrycja L Gradowska; Rosa Meijer; Jacqueline Cloos; Bart J Biemond; Carlos Graux; Marinus van Marwijk Kooy; Markus G Manz; Thomas Pabst; Jakob R Passweg; Violaine Havelange; Gert J Ossenkoppele; Mathijs A Sanders; Gerrit J Schuurhuis; Bob Löwenberg; Peter J M Valk
Journal:  N Engl J Med       Date:  2018-03-29       Impact factor: 91.245

Review 6.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Authors:  Timothy Hughes; Michael Deininger; Andreas Hochhaus; Susan Branford; Jerald Radich; Jaspal Kaeda; Michele Baccarani; Jorge Cortes; Nicholas C P Cross; Brian J Druker; Jean Gabert; David Grimwade; Rüdiger Hehlmann; Suzanne Kamel-Reid; Jeffrey H Lipton; Janina Longtine; Giovanni Martinelli; Giuseppe Saglio; Simona Soverini; Wendy Stock; John M Goldman
Journal:  Blood       Date:  2006-03-07       Impact factor: 22.113

7.  Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Authors:  TaeHyung Kim; Joon Ho Moon; Jae-Sook Ahn; Yeo-Kyeoung Kim; Seung-Shin Lee; Seo-Yeon Ahn; Sung-Hoon Jung; Deok-Hwan Yang; Je-Jung Lee; Seung Hyun Choi; Ja-Yeon Lee; Marc S Tyndel; Myung-Geun Shin; Yoo Jin Lee; Sang Kyun Sohn; Seong-Kyu Park; Zhaolei Zhang; Hyeoung-Joon Kim; Dennis Dong Hwan Kim
Journal:  Blood       Date:  2018-08-14       Impact factor: 22.113

8.  Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.

Authors:  Susan Branford; Paul Wang; David T Yeung; Daniel Thomson; Adrian Purins; Carol Wadham; Nur Hezrin Shahrin; Justine E Marum; Nathalie Nataren; Wendy T Parker; Joel Geoghegan; Jinghua Feng; Naranie Shanmuganathan; Martin C Mueller; Christian Dietz; Doris Stangl; Zoe Donaldson; Haley Altamura; Jasmina Georgievski; Jodi Braley; Anna Brown; Christopher Hahn; Ieuan Walker; Soo-Hyun Kim; Soo-Young Choi; Sa-Hee Park; Dong-Wook Kim; Deborah L White; Agnes S M Yong; David M Ross; Hamish S Scott; Andreas W Schreiber; Timothy P Hughes
Journal:  Blood       Date:  2018-07-02       Impact factor: 22.113

9.  Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.

Authors:  Georgios Nteliopoulos; Alexandra Bazeos; Simone Claudiani; Gareth Gerrard; Edward Curry; Richard Szydlo; Mary Alikian; Hui En Foong; Zacharoula Nikolakopoulou; Sandra Loaiza; Jamshid S Khorashad; Dragana Milojkovic; Danilo Perrotti; Robert Peter Gale; Letizia Foroni; Jane F Apperley
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

Review 10.  European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Authors:  Michele Baccarani; Michael W Deininger; Gianantonio Rosti; Andreas Hochhaus; Simona Soverini; Jane F Apperley; Francisco Cervantes; Richard E Clark; Jorge E Cortes; François Guilhot; Henrik Hjorth-Hansen; Timothy P Hughes; Hagop M Kantarjian; Dong-Wook Kim; Richard A Larson; Jeffrey H Lipton; François-Xavier Mahon; Giovanni Martinelli; Jiri Mayer; Martin C Müller; Dietger Niederwieser; Fabrizio Pane; Jerald P Radich; Philippe Rousselot; Giuseppe Saglio; Susanne Saußele; Charles Schiffer; Richard Silver; Bengt Simonsson; Juan-Luis Steegmann; John M Goldman; Rüdiger Hehlmann
Journal:  Blood       Date:  2013-06-26       Impact factor: 22.113

View more
  1 in total

1.  Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review.

Authors:  Martin Vu; Koen Degeling; Ella R Thompson; Piers Blombery; David Westerman; Maarten J IJzerman
Journal:  Eur J Haematol       Date:  2022-03-02       Impact factor: 3.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.